Table III.
Variable | MEN | WOMEN | Training effect | Gender effect | Interaction effect | ||
---|---|---|---|---|---|---|---|
| |||||||
PRE | POST | PRE | POST | ||||
Type I | 30.7±4.0 | 30.7±3.6 | 33.9±2.9 | 33.9±3.4 | F1,15=0.0001 NS |
F1,15=0.6191 NS |
F1,15=0.0003 NS |
Type IIa | 53.2±2.8 | 55.7±3.6 | 48.6±2.2 | 53.7±2.4 | F1,15=4.8433 p=0.0438 |
F1,15=0.9971 NS |
F1,15=0.5628 NS |
Type IIx | 16.2±3.2 | 13.6±3.6 | 17.5±3.3 | 12.4±2.2 | F1,15=5.0362 p=0.0403 |
F1,15=0.0001 NS |
F1,15=0.5444 NS |
Type I mRNA | 31.2±3.3 | 30.6±3.1 | 32.2±2.3 | 33.9±2.8 | F1,15=0.1100 NS |
F1,15=0.3871 NS |
F1,15=0.5623 NS |
Type IIa mRNA | 53.0±3.2 | 60.5±2.7 | 50.3±2.8 | 58.4±2.7 | F1,15=19.1588 p=0.0005 |
F1,15=0.5357 NS |
F1,15=0.0250 NS |
Type IIx mRNA | 15.7±4.0 | 8.9±3.5 | 17.5±4.4 | 7.7±2.2 | F1,15=10.1120 p=0.0062 |
F1,15=0.0071 NS |
F1,15=0.3403 NS |
Data are mean ± standard error. Statistical significance was determined by RM-ANOVA, and is reported for p < 0.05. NS, not significant.